(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride,
1354486-07-9,
Tofacitinib Impurity 02,
cis-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride,
477600-68-3,
CIS-1-BENZYL-3-(METHYLAMINO)-4-METHYLPIPERIDINE DIHYDROCHLORIDE,
CVQNXCBXFOIHLH-CIKMBUIBSA-N,
MFCD09864744,
C14H22N2.2ClH,
SCHEMBL2148084,
CTK6I1333,
KS-00000HGG,
DTXSID50716624,
CS-M1988,
2871AH,
MFCD11841111,
AKOS015844889,
AKOS015894598,
AF-0011,
RP15817,
SB22747,
SC-93228,
cisbenzyldimethylpiperidinaminedihydrochloride,
DB-059460,
TC-308085,
I05-1623,
cis-1-Benzyl-3-(methylamino)-4-methylpiperidine diHCl,
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine--hydrogen chloride (1/2),
3-Piperidinamine pound notN pound not4-dimethyl-1-(phenylmethyl)- pound not h,
racemic cis-(1-benzyl-4-methyl-piperidine-3-yl)-methylamine bis hydrochloride,
1062580-52-2,
(3S,4S)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE,
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride,
cis-N-Benzyl-3-methylamino-4-methyl-piperidine Bis-(hydrochloride),
22921-68-2,